Clinical investigator responsibilities

Journal of Oncology Practice

Volumn 7, Issue 2, 2011, Pages 124-128

  Baer, Allison R ^a,b,c,d   Devine, Susan ^a,b,c,d   Beardmore, Chris David ^a,b,c,d   Catalano, Robert ^a,b,c,d  

^a AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Translational Research Management   (United States)

^d Eastern Cooperative Oncology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BENEFICENCE; CLINICAL PROTOCOL; CLINICAL RESEARCH; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; JUSTICE; MEDICAL DOCUMENTATION; MEDICAL ETHICS; PATIENT RIGHT; PATIENT SAFETY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RESEARCH ETHICS; REVIEW; STUDY DESIGN;

EID: 79960154703     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2010.000216     Document Type: Review

References (19)

1. International Conference on Harmonisation, Good Clinical Practice (ICH GCP). 1.34 Investigator. http://ichgcp.net/?page-id=377
2. Zon R, Meropol N, Catalano R, et al: American Society of Clinical Oncology statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol, 2562-2567, 2008
3. US Department of Health and Human Services, Office for Human Subjects Research: Belmont Report. Ethical Principles and Guidelines for the Protection of Human Subjects of Research. http://www.hhs.gov/ohrp/humansubjects/guidance/ belmont.html
4. International Conference on Harmonization, Good Clinical Practice (ICH GCP). 1.36 investigator's brochure. http://ichgcp.net/?page-id=381
5. Society of Clinical Research Associates: Education. http://www.socra.org/ html/education.htm
6. Public Responsibility in Medicine and Research: Education. http://www.primr.org/Education.aspx?id=34&linkidentifier=id&itemid=34
7. Collaborative Institutional Training Initiative. http://www.citiprogram. org/Default.asp
8. Cancer.Net.Clinical Trials: www.cancer.net/clinicaltrials
9. US Department of Health and Human Services: USGOVHHS. http://www.youtube.com/user/USGOVHHS#g/c/5965CB14C2506914
10. US Food and Drug Administration: Statement of investigator (Title 21, Code of Federal Regulations Part 312): http://www.fda.gov/downloads/AboutFDA/ ReportsManualsForms/Forms/UCM074728.pdf
11. US Food and Drug Administration: FAQs on debarments/disqualifications: Questions and answers on debarments and disqualifications. http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm176043.htm
12. US Food and Drug Administration: Information Sheet Guidance For Sponsors, Clinical Investigators, and IRBs. Frequently Asked Questions - Statement of Investigator (Form FDA 1572). http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/UCM214282.pdf
13. US Food and Drug Administration: Investigational New Drug Application, Code of Federal Regulations, 21CFR312.3. http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=312.3
14. US Food and Drug Administration: Financial Disclosure by Clinical Investigators. Guidance for Industry - Financial Disclosure by Clinical Investigators: http://www.fda.gov/RegulatoryInformation/Guidances/ucm126832.htm
15. National Archives and Records Administration: Electronic Code of Federal Regulations. Title 42: Public Health. Part 50 - Policies of General Applicability, Subpart F-Responsibility of Applicants for Promoting Objectivity in Research for Which PHS Funding Is Sought. http://ecfr.gpoaccess.gov/cgi/t/ text/text-idx?c=ecfr&sid=4f72164d081005208534c21a08d7dde1&rgn= div6&view=text&node=42:1.0.1.4.22.6&idno=42
16. National Cancer Institute, Cancer Therapy Evaluation Program: Investigator's Handbook. A Manual for Participants in Clinical Trials of Investigational Agents Sponsored by DCTD, NCI. http://ctep.cancer.gov/ investigatorResources/investigators-handbook.htm
17. Cancer Trials Support Unit: About the CTSU. http://www.ctsu.org
18. US Department of Health and Human Services, Office for Human Research Protections: Guidance on Reviewing and Reporting Unanticipated Problems Involving Risks to Subjects or Others and Adverse Events. http://www.hhs.gov/ ohrp/policy/advevntguid.html
19. US Food and Drug Administration: Guidance for Clinical Investigators, Sponsors, and IRBs. Adverse Event Reporting to IRBs-Improving Human Subject Protection. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ UCM126572.pdf